Tomivosertib

DB15219InvestigationalSmall molecule

Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC).

Chemical structure of Tomivosertib
Formula / weight
C17H20N6O2 · 340.387 g/mol (avg)
Code names
EFT-508

Resolves to

Compound
UNIIU2H19X4WBVCAS1849590-01-7ChEMBLCHEMBL4073443
Structure
InChIKeyHKTBYUWLRDZAJK-UHFFFAOYSA-NSMILESCC1=C2N(C(=O)C(NC3=CC(N)=NC=N3)=C1)C1(CCCCC1)NC2=O
Targets
Q9HBH9MKNK2Q9BUB5MKNK1

What you can answer from here — as of July 17, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tomivosertib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In